Health

Chulalongkorn Bariatric and Metabolic Institute (Chula BMI), a One-Stop Service Center for Holistic Obesity Treatment

BANGKOK, Sept. 16, 2025 /PRNewswire/ -- Say goodbye to obesity with the  Chulalongkorn Bariatric and Metabolic Institute (Chula BMI) —King Chulalongkorn Memorial Hospital 's one-stop center for...

2025-09-16 10:00 2163

Innovent to Present Multiple R&D Results of General Biomedicine Pipeline at the 34th EADV Congress 2025

SAN FRANCISCO and SUZHOU, China, Sept. 15, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metaboli...

2025-09-16 09:00 1564

Baxter Launches HEMOPATCH Sealing Hemostat in New Zealand, a Room-Temperature Collagen Pad Approved for Hemostasis and Sealing

DEERFIELD, Ill., Sept. 15, 2025 /PRNewswire/ -- Over the past two decades, surgical techniques have increasingly shifted toward minimally invasive approaches, requiring adapted workflows and skillsets. At the same time, patient complexity has grown, calling for tailored strategies to support safe...

2025-09-16 06:00 1631

LBB Specialties and Imerys Form Specialty Distribution Partnership in North America

NORWALK, Conn., Sept. 16, 2025 /PRNewswire/ -- LBB Specialties (LBBS), a leader inspecialty chemicals and ingredient distribution inN...

2025-09-16 01:00 1426

Glac Biotech Secures U.S. Food and Drug Administration GRAS Approval for Probiotic Strain CP-9

TAIPEI, Sept. 15, 2025 /PRNewswire/ -- Glac Biotech, a Taiwan-based developer of probiotics and postbiotics, announced that its core probiotic strain CP-9 (Bifidobacterium lactis CCTCC M 2014588) has been approved with Generally Recognized as Safe (GRAS) status by the U.S. Food and Drug Administr...

2025-09-15 22:00 1824

HitGen Partner BioAge Labs Initiates Phase 1 Clinical Study of BGE-102, a Novel Brain-Penetrant NLRP3 inhibitor

* BGE-102, an orally available, brain-penetrant NLRP3 inhibitor, was developed from a hit compound identified using HitGen's industry-leading DEL technology platform, highlighting the value of DEL to accelerate innovative drug development. * The initiation of the BGE-102 Phase 1 clinical stud...

2025-09-15 21:30 1593

LabConnect and OmniScience to Deliver First Agentic AI Solution for Real-Time Clinical Trial Lab Insights

Together we're unlocking the true potential of clinical trial lab data, bringing faster insights, smarter decisions, and better outcomes. JOHNSON CITY, Tenn. and HOUSTON, Sept. 15, 2025 /PRNewswire/ -- LabConnect, a leading global provider of central laboratory services today announced plans to ...

2025-09-15 21:03 1502

EmeTerm Wearable Device Under Clinical Study at Ohio State Wexner Medical Center Shows Promise for Chronic Nausea Patients

VANCOUVER, BC, Sept. 15, 2025 /PRNewswire/ -- WAT Medical Enterprise Ltd. is proud to announce that its innovative anti-nausea wristband, EmeTerm, has made significant progress in alleviating nausea and vomiting among patients suffering from chronic gastric disorders. A clinical study currently u...

2025-09-15 21:00 1289

AMPLIFON: -42% DIRECT EMISSIONS AND -25% INDIRECT GREENHOUSE GAS EMISSIONS BY 2030

MILAN, Sept. 15, 2025 /PRNewswire/ -- Amplifon, a global leader in hearing solutions and services, is launching itsclimate strategy validated by the Science Based Targets Initiative (SBTi)to reduce greenhouse gas emissions and contribute to achieving the goals of the 2015 Paris Agreement to count...

2025-09-15 20:37 2020

Korea reinforces biopharma leadership at Global Bio Conference 2025

SEOUL, South Korea, Sept. 15, 2025 /PRNewswire/ -- This is an article published in The Korea Herald: The Ministry of Food and Drug Safety on Thursday announced its successful hosting of the Global Bio Conference 2025 inSeoul last week, under the theme "Bio, Navigating Infinite Possibilities." T...

2025-09-15 20:30 1530

Kolmar Korea Advances 'Clean Beauty' with Breakthroughs from Eco-Friendly Packaging to R&D

* Sweeps global awards with eco-friendly packaging innovations, including paper tube, paper stick, and paper pack * Ranked No. 125 on TIME's "World's Best Companies for Sustainable Growth 2025," the only K-Beauty company on the list SEOUL, South Korea, Sept. 15, 2025 /PRNewswire/ -- Kolmar Ko...

2025-09-15 20:30 2955

SI GROUP TO SHOWCASE SUSTAINABLE ADDITIVE INNOVATIONS AT K 2025

Industry Leader Presents Advanced Solutions for Plastics and Rubber THE WOODLANDS, Texas, Sept. 15, 2025 /PRNewswire/ -- SI Group, a leading global developer and manufacturer of performance additives, process solutions, pharmaceuticals, and chemical intermediates, will showcase its portfolio of ...

2025-09-15 20:30 1481

Rona Therapeutics Announces IND Filing of RN3161, a Highly Potent and Durable INHBE siRNA for Obesity

SHANGHAI and SANTA BARBARA, Calif., Sept. 15, 2025 /PRNewswire/ -- Rona Therapeutics, a global leader in developing next-generation RNAi therapeutics, announced today the successful submission of RN3161 to the Australian Human Research Ethics Committee (HREC).RN3161 is a proprietary GalNAc-conjug...

2025-09-15 20:00 1523

FutureCeuticals Files Lawsuit Against NeuroRush Owner for Patent Infringement over Alleged Copycat Ingredient

MOMENCE, Ill., Sept. 15, 2025 /PRNewswire/ -- VDF FutureCeuticals, Inc. filed a lawsuit against Aura Scientific, asserting that its brain performance ingredient NeuroRush – an extract of whole coffee fruit – infringes multiple of FutureCeuticals' patents covering technology relating to coffee fru...

2025-09-15 20:00 2418

Biostar Pharma Successively Achieved First Patient Dosing for Two Phase II/III Multiregional Clinical Trials of Utidelone Capsule (UTD2)

SAN FRANCISCO, Sept. 15, 2025 /PRNewswire/ -- Biostar Pharma, Inc., the US subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. ("Biostar", Stock Code: 2563.HK) which is a synthetic biology driven biopharma company focusing on the discovery, development and commercialization of innovative onco...

2025-09-15 20:00 1183

Medit Link Express for iPad Debuts as Medit i900 Mobility Goes into Shipping

SEOUL, South Korea, Sept. 15, 2025 /PRNewswire/ -- Medit (www.medit.com ), a global leader in digital dentistry, today announced two milestone moments for the industry. The company has officially launched Medit Link Express, its first iPad-native app ...

2025-09-15 19:00 1780

Sunsred Launches FDA-cleared Red Light Therapy Devices for Wellness Brands Worldwide

SHENZHEN, China, Sept. 15, 2025 /PRNewswire/ -- Shenzhen Sunsred Technology Co., Ltd. is shaking things up in the wellness tech world with its latest lineup of red light therapy devices. As a go-toOEM/ODM red light therapy manufacturer in this space, Sunsred is meeting the huge global demand for ...

2025-09-15 19:00 1152

Clinically Proven Human Milk Probiotic LC40® supports Infant Health and Breastfeeding Mothers

SINGAPORE, Sept. 15, 2025 /PRNewswire/ -- Supported by six clinical studies and two safety trials,Kerry 's LC40® is the first probiotic strain of its kind validated for both infant and maternal applications, offering a natural, science-backed approach to early life and...

2025-09-15 18:20 1744

Akeso Announces First Patient Dose in Global Registrational Trial of Cadonilimab (PD-1/CTLA-4) for PD-1 Treatment-Resistant Hepatocellular Carcinoma

HONG KONG, Sept. 15, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in its global, multicenter, randomized Phase II registrational trial (COMPASSION-36/AK104-225). The trial will evaluate cadonilimab, Akeso's first-in-class P...

2025-09-15 12:11 1785

Jointly discovered KAT6i molecule originating from Australian research has initiated Phase 3 in HR+ HER2- Breast Cancer with Pfizer Inc

Australian scientists who discovered how to "turn off" genes that make cancer cells grow are celebrating the next phase of development – with Pfizer's first in class KAT6 inhibitor PF-07248144 now moving to the next stages of clinical investigation. MELBOURNE, Australia, Sept. 15, 2025 /PRNewswi...

2025-09-15 12:06 1374
1 ... 47484950515253 ... 873

Week's Top Stories